187 related articles for article (PubMed ID: 15661214)
1. Matrix metalloproteinase 1 gene polymorphism as a prognostic predictor of invasive cervical cancer.
Lai HC; Chu CM; Lin YW; Chang CC; Nieh S; Yu MH; Chu TY
Gynecol Oncol; 2005 Feb; 96(2):314-9. PubMed ID: 15661214
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor (TIMP-2) are prognostic factors in cervical cancer, related to invasive disease but not to high-risk human papillomavirus (HPV) or virus persistence after treatment of CIN.
Branca M; Ciotti M; Giorgi C; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Syrjänen S; Favalli C; Syrjänen K;
Anticancer Res; 2006; 26(2B):1543-56. PubMed ID: 16619570
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphism of the interferon-gamma gene in cervical carcinogenesis.
Lai HC; Chang CC; Lin YW; Chen SF; Yu MH; Nieh S; Chu TW; Chu TY
Int J Cancer; 2005 Feb; 113(5):712-8. PubMed ID: 15499631
[TBL] [Abstract][Full Text] [Related]
4. Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix.
Yamashita T; Yaginuma Y; Saitoh Y; Kawai K; Kurakane T; Hayashi H; Ishikawa M
Carcinogenesis; 1999 Sep; 20(9):1733-6. PubMed ID: 10469618
[TBL] [Abstract][Full Text] [Related]
5. Down-regulated nucleoside diphosphate kinase nm23-H1 expression is unrelated to high-risk human papillomavirus but associated with progression of cervical intraepithelial neoplasia and unfavourable prognosis in cervical cancer.
Branca M; Giorgi C; Ciotti M; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Mariani L; Ruutu M; Favalli C; Syrjänen K;
J Clin Pathol; 2006 Oct; 59(10):1044-51. PubMed ID: 16537673
[TBL] [Abstract][Full Text] [Related]
6. Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesis.
Lai HC; Sytwu HK; Sun CA; Yu MH; Yu CP; Liu HS; Chang CC; Chu TY
Int J Cancer; 2003 Jan; 103(2):221-5. PubMed ID: 12455036
[TBL] [Abstract][Full Text] [Related]
7. Impact of matrix metalloproteinase-11 gene polymorphisms on development and clinicopathologcial variables of uterine cervical cancer in Taiwanese women.
Ng SC; Wang PH; Lee YC; Lee CY; Yang SF; Shen HP; Hsiao YH
Int J Med Sci; 2019; 16(6):774-782. PubMed ID: 31337950
[TBL] [Abstract][Full Text] [Related]
8. MMP-1 and MMP-2 in the cervix uteri in different steps of malignant transformation--an immunohistochemical study.
Brummer O; Böhmer G; Hollwitz B; Flemming P; Petry KU; Kühnle H
Gynecol Oncol; 2002 Feb; 84(2):222-7. PubMed ID: 11812078
[TBL] [Abstract][Full Text] [Related]
9. Expression of membrane type 1 matrix metalloproteinase is associated with cervical carcinoma progression and invasion.
Zhai Y; Hotary KB; Nan B; Bosch FX; Muñoz N; Weiss SJ; Cho KR
Cancer Res; 2005 Aug; 65(15):6543-50. PubMed ID: 16061633
[TBL] [Abstract][Full Text] [Related]
10. CCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women.
Chatterjee K; Dandara C; Hoffman M; Williamson AL
BMC Cancer; 2010 Jun; 10():278. PubMed ID: 20537184
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.
Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J
Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of human papillomavirus genotype by linear array assay in Japanese women with uterine cervical lesions and type 16 physical status by in situ hybridization.
Futai M; Watanabe J; Jobo T; Tsunoda S; Nishimura Y; Watanabe K; Okayasu I; Unno N
Int J Gynecol Cancer; 2009 Nov; 19(8):1396-401. PubMed ID: 20009896
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of FAS and FASL (CD95/CD95L) genes in cervical carcinogenesis: An analysis of haplotype and gene-gene interaction.
Lai HC; Lin WY; Lin YW; Chang CC; Yu MH; Chen CC; Chu TY
Gynecol Oncol; 2005 Oct; 99(1):113-8. PubMed ID: 15996722
[TBL] [Abstract][Full Text] [Related]
14. Analysis of cytosine-adenine repeats in P1 promoter region of IGF-1 gene in peripheral blood cells and cervical tissue samples of females with cervical intraepithelial lesions and squamous cervical cancer.
Kwasniewski W; Gozdzicka-Jozefiak A; Kotarska M; Polak G; Barczynski B; Broniarczyk J; Nowak W; Wolun-Cholewa M; Kwasniewska A; Kotarski J
Mol Med Rep; 2015 Feb; 11(2):766-74. PubMed ID: 25384883
[TBL] [Abstract][Full Text] [Related]
15. MTHFR/p53 polymorphisms as genetic factors for cervical intraepithelial neoplasia and cervical cancer in HPV-infected Mexican women.
González-Herrera L; Rodríguez-Morales P; Gonza Lez-Losa Mdel R; Pérez-Mendoza G; Canul-Canché J; Rosado-López I; Cetina TC
Int J Biol Markers; 2014 Jun; 29(2):e142-9. PubMed ID: 24474455
[TBL] [Abstract][Full Text] [Related]
16. The expression of p16 and galectin-3 in cervical intraepithelial neoplasia (CIN) and squamous cell carcinoma (SCC) uterine cervix.
Kumar R; Mandal S; Arora P; Mala YM; Khurana N
J Obstet Gynaecol; 2021 Jul; 41(5):785-790. PubMed ID: 33073644
[TBL] [Abstract][Full Text] [Related]
17. Minichromosome Maintenance Complex (MCM) Genes Profiling and MCM2 Protein Expression in Cervical Cancer Development.
Kaur G; Balasubramaniam SD; Lee YJ; Balakrishnan V; Oon CE
Asian Pac J Cancer Prev; 2019 Oct; 20(10):3043-3049. PubMed ID: 31653153
[TBL] [Abstract][Full Text] [Related]
18. A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer.
Shimizu Y; Kondo S; Shirai A; Furukawa M; Yoshizaki T
Auris Nasus Larynx; 2008 Sep; 35(3):381-9. PubMed ID: 18276095
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation of two consecutive tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 in cervical neoplasias.
Lai HC; Lin YW; Chang CC; Wang HC; Chu TW; Yu MH; Chu TY
Gynecol Oncol; 2007 Mar; 104(3):629-35. PubMed ID: 17097722
[TBL] [Abstract][Full Text] [Related]
20. Application of hTERC in thinprep samples with mild cytologic abnormality and HR-HPV positive.
Li Y; Zeng WJ; Ye F; Wang XY; Lü WG; Ma D; Wei LH; Xie X
Gynecol Oncol; 2011 Jan; 120(1):73-83. PubMed ID: 21035173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
